2026 IPO bonanza! Over 90% of new stocks rose on their debut
At a Glance | June’s Hot IPOs: Shougang Langze Set to List, Liu Liu Mei Passed Hearing, Lung Fung Group, Tianchen Bio-B, and Dajin Heavy Industry Now Open for Hot Subscription
Hello, fellow investors! Niu Niu IPO Tracker brings you the hottest Hong Kong IPOs for June and 2026—be sure to check them out!
As of this writing, $SHOUGANG LANZA (02553.HK)$ Subscription has closed. Gray market trading will take place from 16:15 to 18:30 on June 2, with official listing on June 3.
$LUNG FUNG GROUP (02290.HK)$ 、 $LONGBIO-B (01779.HK)$ 、 $DAJIN (01081.HK)$ Heavily subscribed; subscription closes at 10:00 on June 2. Gray market trading will occur from 16:15 to 18:30 on June 4, with official listing on June 5.
![Hello, fellow investors! Niu Niu IPO Tracker brings you the hottest Hong Kong IPOs for June and 2026—be sure to check them out![Cheerlead][Cheerlead] As of this writing, $SHOUGANG LANZA (02553.HK)$ has closed its subscription period, will conduct grey market trading from 16:15 to 18:30 on June 2, and officially list on June 3. $LUNG FUNG GROUP (02290.HK)$ 、 $LONGBIO-B (01779.HK)$ 、 $DAJIN (01081.HK)$ is now open for hot subscription, closing at 10:00 on June 2, with grey market trading scheduled from 16:15 to 18:30 on June 4, and official listing on June 5. Shougang Langze: Shougang Langze is a company operating in the carbon capture, utilization, and storage (CCUS) sector, primarily focused on producing low-carbon products such as ethanol and microbial protein through carbon capture and utilization technologies, and offering integrated low-carbon solutions. Since its establishment in 2011, the company has specialized in the CCUS industry. According to Frost & Sullivan, it is the first company in the CCUS industry to commercialize and scale low-carbon product production using proven synthetic biology technology. Tianchen Bio: Tianchen Bio is a clinical-stage biopharmaceutical company founded in 2020, headquartered in Shanghai and Changshu, Suzhou, China. It focuses on the independent discovery and development of biologics targeting allergic and autoimmune diseases. The company...](https://nnqimage.futunn.com/sns_client_feed/12147652/20260529/web-1780039058229-PPmQ1Lk6Jf.png/big?area=999&is_public=true&imageMogr2/ignore-error/1/format/webp)
Shougang Langze: Shougang Langze is a company operating in the carbon capture, utilization, and storage (CCUS) sector, primarily focused on producing low-carbon products such as ethanol and microbial protein through carbon capture and utilization technologies, and providing integrated low-carbon solutions. Since its establishment in 2011, the company has specialized in the CCUS industry. According to Frost & Sullivan, it is the first company in the CCUS sector to commercialize and scale low-carbon product production using proven synthetic biology technology.
Tianchen Bio: Tianchen Bio is a clinical-stage biopharmaceutical company founded in 2020, headquartered in Shanghai and Changshu, Suzhou, China. It focuses on the independent discovery and development of biologics for allergic and autoimmune diseases. The company has built a comprehensive biologics pipeline targeting conditions in rhinology, dermatology, respiratory medicine, hematology, nephrology, and other autoimmune indications.
Dajin Heavy Industry: Dajin Heavy Industry is a globally leading supplier of core equipment for offshore wind power. With nearly two decades of experience in the wind power industry, it provides large-scale global offshore wind developers with an integrated one-stop solution covering 'manufacturing + transportation + delivery' of wind turbine foundations. The company has proactively positioned itself in the global deepwater offshore wind market, consistently focusing on mainstream global offshore wind markets characterized by high technical standards, stringent quality requirements, and significant commercial potential. Its core businesses include R&D and manufacturing of offshore wind foundations, specialized ocean transport, vessel design and construction, wind and photovoltaic power generation, and offshore wind port operations.
Lung Fung Group: Lung Fung Group is a Hong Kong-based leading retail chain operating under the 'Lung Fung' brand, specializing in beauty products, health supplements, and pharmaceuticals. As of the latest practicable date, the company operates 31 retail stores in Hong Kong and multiple online sales platforms, offering customers a wide selection of high-value products. It possesses strong supply chain procurement capabilities and sources products from over 600 suppliers—including international brand manufacturers and authorized distributors—as of November 30, 2025, ensuring stable and timely product availability.
According to a Hong Kong Stock Exchange disclosure on May 26, Liu Liu Mei passed the HKEX Main Board listing hearing, with China Securities and Guoyuan International acting as joint sponsors. Liu Liu Mei submitted its Main Board listing application to the HKEX on May 21, with China Securities and Guoyuan International as joint sponsors. The company previously filed applications with the HKEX on April 16, 2025, and October 28, 2025.
Which upcoming IPO are fellow investors most excited about? Are there other companies you’re rooting for that could successfully list on the Hong Kong Stock Exchange? Cast your vote and join the discussion in the comments!>>
>>Further reading:
The golden season for new stock subscriptions has arrived! Use Futu for new stock subscriptions—zero interest, zero handling fees, and zero cash subscription. Participants now have the chance to have their new stock subscription fees waived for a year.Come and experience it now >>
![Hello, fellow investors! Niu Niu IPO Tracker brings you the hottest Hong Kong IPOs for June and 2026—be sure to check them out![Cheerlead][Cheerlead] As of this writing, $SHOUGANG LANZA (02553.HK)$ has closed its subscription period, will conduct grey market trading from 16:15 to 18:30 on June 2, and officially list on June 3. $LUNG FUNG GROUP (02290.HK)$ 、 $LONGBIO-B (01779.HK)$ 、 $DAJIN (01081.HK)$ is now open for hot subscription, closing at 10:00 on June 2, with grey market trading scheduled from 16:15 to 18:30 on June 4, and official listing on June 5. Shougang Langze: Shougang Langze is a company operating in the carbon capture, utilization, and storage (CCUS) sector, primarily focused on producing low-carbon products such as ethanol and microbial protein through carbon capture and utilization technologies, and offering integrated low-carbon solutions. Since its establishment in 2011, the company has specialized in the CCUS industry. According to Frost & Sullivan, it is the first company in the CCUS industry to commercialize and scale low-carbon product production using proven synthetic biology technology. Tianchen Bio: Tianchen Bio is a clinical-stage biopharmaceutical company founded in 2020, headquartered in Shanghai and Changshu, Suzhou, China. It focuses on the independent discovery and development of biologics targeting allergic and autoimmune diseases. The company...](https://nnqimage.futunn.com/sns_client_feed/12147652/20260529/web-1780039058367-vaZkgUBeJq.png/big?area=999&is_public=true&imageMogr2/ignore-error/1/format/webp)
Editor/Joe
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Comments (4)
to post a comment
15
14